User Experience and Effects of an Individually Tailored Transdiagnostic Internet-Based and Mobile-Supported Intervention for Anxiety Disorders: Mixed-Methods Study by Weisel, Kiona K et al.
Original Paper
User Experience and Effects of an Individually Tailored
Transdiagnostic Internet-Based and Mobile-Supported Intervention
for Anxiety Disorders: Mixed-Methods Study
Kiona K Weisel1, MSc; Anna-Carlotta Zarski1, PhD; Thomas Berger2, PhD; Tobias Krieger2, PhD; Christian T Moser2,
MSc; Michael P Schaub3, PhD; Dennis Görlich4, PhD; Matthias Berking1, PhD; David D Ebert5, PhD
1Department of Clinical Psychology and Psychotherapy, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
2Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland
3Swiss Research Institute of Public Health and Addiction ISGF, Associated to the University of Zurich, Zurich, Switzerland
4Institute of Biostatistics and Clinical Research, Westfälische Wilhelms-Universität Münster, Münster, Germany
5Clinical, Neuro- & Development Psychology, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
Corresponding Author:
Kiona K Weisel, MSc





Phone: 49 (0)9131 ext 8567570
Email: kiona.weisel@fau.de
Abstract
Background: Internet interventions have been shown to be effective in treating anxiety disorders. Most interventions to date
focus on single disorders and disregard potential comorbidities.
Objective: The aim of this mixed-methods study was to investigate feasibility, user experience, and effects of a newly developed
individually tailored transdiagnostic guided internet intervention for anxiety disorders.
Methods: This study is an uncontrolled, within-group, baseline, postintervention pilot trial with an embedded qualitative and
quantitative process and effect evaluation. In total, 49 adults with anxiety disorders (generalized anxiety disorder n=20, social
phobia n=19, agoraphobia without panic n=12, panic with agoraphobia n=6, panic without agoraphobia n=4, subclinical depression
n=41) received access to the 7-session intervention. We examined motivation and expectations, intervention use, user experience,
impact, and modification requests. Qualitative data were assessed using semistructured interviews and analyzed by qualitative
content analysis. Quantitative outcomes included symptom severity of anxiety and depression (Hamilton Anxiety Rating Scale
[HAM-A], Quick Item Inventory of Depressive Symptomatology clinician rating [QIDS-C]), diagnostic status in clinical interviews
(Mini International Neuropsychiatric Interview [MINI]), and web-based self-reports (Generalized Anxiety Disorder–7 [GAD-7],
Center for Epidemiological Studies Depression Scale [CES-D], Beck Anxiety Inventory [BAI], Panic and Agoraphobia Scale
[PAS], Social Phobia Scale [SPS], Patient Health Questionnaire–9 [PHQ-9]) at baseline and postassessment. Quantitative data
was analyzed by comparing within-group means expressed as Cohen d.
Results: Anxiety symptom severity (HAM-A d=1.19) and depressive symptoms (QIDS-C d=0.42) improved significantly, and
54% (21/39) no longer were diagnosed as having any anxiety disorder. The main positive effects were the general improvement
of disease burden and attentiveness to feelings and risk situations while the main negative effects experienced were lack of change
in disease burden and symptom deterioration. The most prevalent reasons for participation were the advantages of online treatment,
symptom burden, and openness toward online treatment. Helpful factors included support, psychoeducation and practicing
strategies in daily life; the main hindering factors were too little individualization and being overwhelmed by the content and
pace.
Conclusions: The intervention was found to be feasible and results show preliminary data indicating potential efficacy for
improving anxiety and depression. The next step should be the evaluation within a randomized controlled trial. Concerning
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intervention development, it was found that future interventions should emphasize individualization even more in order to further
improve the fit to individual characteristics, preferences, and needs.
(J Med Internet Res 2020;22(9):e16450) doi: 10.2196/16450
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Introduction
Internet interventions can be effective means of treating mental
health problems such as anxiety disorders [1-3]. Anxiety
disorders are highly prevalent [4], and individuals suffering
from anxiety disorders tend to experience significant impairment
in quality of life and a decreased sense of well-being and
occupational and family satisfaction [5,6]. Anxiety disorders
have also been found to be highly comorbid and act as risk
factors for developing other anxiety disorders (comorbidity rate
of patients with generalized anxiety disorder in the past 12
months and any other anxiety disorder: 55.9%) or major
depressive disorder (comorbidity of generalized anxiety disorder
and major depressive disorder: 59.1%) [7-10].
The fact that the majority of individuals who suffer from a
mental disorder do not receive treatment is a demanding public
health issue [11]. One primary reason for nontreatment seeking
behavior apart from structural barriers such as treatment
availability is attitudinal barriers including preference for
self-reliance, low perceived treatment need, poor mental health
literacy, and fear of stigmatization [12-14]. Internet interventions
offer many advantages that could help bridge this treatment
gap. Meta-analytic evidence has found internet interventions to
be efficacious with medium to large effect sizes for the treatment
of anxiety disorders [3,15-17].
As anxiety disorders are often comorbid with other anxiety
disorders and depression [7-9], there are advantages to treating
all comorbid disorders within one transdiagnostic treatment
protocol. Transdiagnostic treatment for anxiety disorders and
depression can be applied to a broad range of patients regardless
of their primary diagnosis as they are designed to target common
underlying factors and also provide a variety of treatment
[18,19]. Research investigating internet-based transdiagnostic
treatment protocols for different anxiety disorders and comorbid
depression has found these type of interventions to be efficacious
[20-22].
Recently, there have been attempts to further individualize
treatments according to the symptom profile and preferences
of patients, which is also referred to as individual tailoring
[23-25]. Beyond being able to address comorbidities, the main
advantage is that patient preferences are considered in the
treatment protocol, which could increase treatment motivation
and therefore adherence and ideally also improve the outcome
[26]. One trial found that effects in an internet-based
intervention for depression were more pronounced when
individual tailoring was applied compared with standardized
treatment indicating the potential of individual tailoring [23].
To the best of our knowledge, no meta-analytic review exists
on the sole effect of tailoring; however, meta-analytic evidence
proposes that transdiagnostic and individual tailored approaches
are promising when dealing with comorbidity with medium to
large effect sizes for anxiety (g=0.82) and depression: (g=0.79)
[27].
Some general aspects that remain unknown in internet
interventions are (1) why individuals choose to participate, (2)
how such interventions work including helpful and hindering
factors [17,28,29], and (3) subjective impact including negative
effects [30]. One way to explore these themes is through
interviews with participants and qualitative data analysis.
The aim of this pilot feasibility study is to investigate a newly
developed individually tailored transdiagnostic guided internet
intervention for anxiety disorders with and without comorbid
subclinical depression and explore feasibility. Qualitative and
quantitative data and methods will be used to understand user
experience focusing on motivation for participation and initial
expectations, intervention use, and helpful and hindering factors.
The impact of the intervention is explored through qualitative
interviews as well as self-report and clinician-rated diagnostics
on symptom severity, occurrence of clinical diagnoses, and
positive and negative training effects. Finally, suggestions for
intervention improvement and development will be derived.
Methods
The paper describes the findings of a pilot feasibility study for
a randomized controlled trial that was registered in the German
Clinical Trials Register [DRKS00012656] and received ethical
approval from Friedrich-Alexander University
Erlangen-Nürnberg (144-16 B).
Recruitment
Participants were recruited via German health insurance
companies, a study webpage, and open recruitment strategies
such as social media and Google Ads for a primary trial on the
prevention of depression and anxiety [31]. Individuals with a
clinical diagnosis of a major depressive disorder in the screening
process were referred to another trial [32]. If they did not fulfill
the criteria of the prevention trial due to a clinical diagnosis of
an anxiety disorder and did not have a clinical diagnosis of
major depressive disorder, they were referred to this study.
Assessment of Eligibility
Participants were eligible to participate in the study if they
fulfilled the following inclusion criteria of having a current
diagnosis of an anxiety disorder (generalized anxiety disorder,
panic disorder, agoraphobia, social phobia) assessed in the
diagnostic interview based on the Mini International
Neuropsychiatric Interview (MINI) [33] and signed informed
consent without any of the following exclusion criteria: (1)
history of psychosis, (2) bipolar disorder, (3) psychological
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treatment in the past 6 months, (4) currently on a waiting list
for psychological treatment, (5) heightened suicidality, (6)
having a current, or past 6 months, episode of a major depressive
disorder. To increase internal validity, we decided not to include
individuals with a major depressive disorder and redirected
them to a different trial [32] as we assumed they might have
other characteristics and needs.
Study Design
The study has an uncontrolled, within-group, baseline,
postintervention design with an embedded qualitative and
quantitative process evaluation. All participants (n=49) included
in this study received access to the individually tailored
transdiagnostic guided treatment for anxiety disorders. Clinical
diagnostic interviews on diagnostic status and symptom severity
of anxiety disorders and major depressive disorder were
conducted at baseline and postassessment 8 weeks after
intervention allocation. The participants also completed
web-based self-report assessments on anxiety and depressive
symptom severity and a question on treatment motivation and
guidance preference at baseline and postassessment. A
semistructured qualitative interview was conducted at
postassessment. Figure 1 displays the study flow.
Figure 1. Study flow.
Intervention
The internet intervention comprises 7 sessions plus one booster
session. The content includes psychoeducation; methods to
reduce incongruence between personal values, needs, and
behavior; behavioral activation; exposure; and problem solving.
The intervention is mainly text-based with additional elements
such as short educational videos and audio files. To promote
the transfer of acquired skills into daily life, participants could
opt to receive short messages to their phone throughout the day
(sent through an app or a messaging service) with motivational
sentences or mini tasks referred to as Tiny Tasks. For more
information on the reported intervention, see the published study
protocol of the primary prevention trial [31]. See Textbox 1 for
an overview of the intervention sessions.
J Med Internet Res 2020 | vol. 22 | iss. 9 | e16450 | p. 3http://www.jmir.org/2020/9/e16450/
(page number not for citation purposes)
Weisel et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
Textbox 1. Session overview and elective modules.
1. Behavioral activation: satisfying needs and goals
• Introduction to the training and core elements
• Strengthening motivation and personal goal setting
• Understanding the relationship between personal needs and values and identifying discrepancies
• Planning activities to strengthen core values
2. Behavioral activation: overcoming difficulties and pleasant activity scheduling
• Overcoming difficulties of behavioral activation
• Understanding the nature of avoidant behaviors
• Planning mood-enhancing activities
3. Psychoeducation
• Psychoeducational information on depression and anxiety including etiological and maintaining factors
• Identifying individual symptomatology and course of development
4. Cognitive restructuring
• Introduction to the causal relationship between cognitions and emotions
• Application of a thought record
• Identifying automatic negative thoughts and practicing cognitive flexibility
5. Exposure I or Problem solving I
• Practicing problem solving by distinguishing between solvable and unsolvable problems and applying a 6-step problem-solving plan
• Practicing exposition to fear-inducing situations based on a personal fear hierarchy
6. Exposure II or Problem solving II
7. Plan for the future
• Recap of the training
• Plan for the future and relapse prevention
8. Booster session
• Reflecting on goal attainment
• Further planning of the future
Elective modules: rumination and worries, acceptance, relaxation, reducing alcohol, self-worth, perfectionism, appreciation and gratitude, sleep
Individual Tailoring
During the intervention development phase, there was an
emphasis on individual tailoring which manifested itself through
(1) tailoring to core clinical characteristics (any anxiety disorder
or depression); (2) receiving optional Tiny Tasks; (3) choosing
elective modules on various psychological topics such as
acceptance, relaxation, or reducing alcohol based on interest,
preference, and needs; (4) personal goal setting with monitoring
of advancement in achieving goals and making adjustments
throughout the intervention; (5) receiving personalized guidance
by eCoaches who also monitored individual intervention use
through adherence. The presented content in the intervention is
triggered by patient input.
Guidance and Adherence Monitoring
After completion of a session, patients receive written
content-focused feedback by an eCoach. eCoaches are
supervised psychologists or psychotherapists (in training) who
provide manualized text-based feedback and monitor for
adherence and potential crises throughout the intervention. In
case of noncompliance to the intervention, eCoaches send
reminder messages to encourage session completion. Patients
are also sent automatic weekly email reminders by the platform
in case of nonadherence.
Assessments and Data Management
Qualitative Data
The interview manual was developed in collaboration with
clinical experts and comprises 7 open questions including
reasons for participation and expectations, training experience
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including helpful and hindering factors, impact of treatment,
and modification requests. All participants were asked to
participate in the qualitative interviews regardless of their actual
treatment progress, intervention adherence, or session
completion rates. Table 1 gives an overview of the topical
domains and interview questions translated into English. The
interviews were recorded and the content was transcribed
verbatim.
Table 1. Overview of interview questions and domains.
QuestionDomainCode
Why did you participate in the online training?Motivation for participationQ1
Which expectations toward the training were fulfilled?Fulfilled expectationsQ2
Which expectations toward the training were not fulfilled?Unfulfilled expectationsQ3
How has your disease burden changed by using the online training?Impact of online trainingQ4
What part of the training was particularly helpful in improving your psychological well-being?Helpful training eventQ5
What would you have needed in addition from the training to help improve your psychological well-being?Hindering training elementQ6
Which elements of the training had no or negative effects on your psychological well-being?Negative effectsQ7
Quantitative Assessments
Quantitative assessments took place during screening to
complete study inclusion, at baseline before intervention access,
and after intervention completion (8 weeks after baseline).
Assessments comprised diagnostic interviews conducted by
clinicians via telephone and web-based self-report assessments.
The clinicians were blind to the fact that there was no control
group. Figure 1 displays the study flow. The web-based
assessments included measures of anxiety symptom severity,
depression symptom severity, a question on treatment
motivation, and guidance preference.
Anxiety disorders and major depressive disorder were assessed
by an adaption of the MINI 5.0 [34]. Severity of anxiety
symptoms was assessed by the Hamilton Anxiety Rating Scale
(HAM-A; 14 items; αT1=.76) [35,36] and the Quick Item
Inventory of Depressive Symptomatology clinician rating
(QIDS-C; 16 Items; αT1=.64) [37,38] via telephone by diagnostic
raters.
Generalized anxiety disorder and symptom severity were
measured by the Generalized Anxiety Disorder 7 (GAD-7; 7
items; αT1=.82) [39,40]. The Beck Anxiety Inventory (BAI; 21
items; αT1=.91) was used to assess clinical anxiety [41]. Panic
and agoraphobia symptoms were assessed by the Panic and
Agoraphobia Scale (PAS; 13 items; αT1=.89) [42]. The Social
Phobia Scale assessed social anxiety and pertains to fears of
scrutiny during observations by others (SPS; 20 items; αT1=.93)
[43,44].
Depressive symptoms were also assessed by the Patient Health
Questionnaire (PHQ-9; 9 items; αT1=.73) [45] and the Center
for Epidemiological Studies Depression Scale (CES-D; 20 items;
αT1=.68) [46,47].
Motivation to receive online treatment as well as guidance
preference were assessed by prompting participants to choose
from a set of predefined answers in the web-based assessment.
For an overview of all possible answers, see Multimedia
Appendix 1.
Study Adherence
Adherence to study completion was monitored. To standardize
the study adherence procedure, a systematic adherence protocol
was instated. After noncompletion of an assessment or the
diagnostic interview, participants were sent reminder emails
after 7, 14, 21, and 28 days and text messages after 14, 21, and
28 days; reminder calls took place after 21 days. The text
messages contained different motivational approaches to appeal
to different mindsets such as helping others by providing data,
having received the training in exchange for completing
assessments, furthering scientific evidence, and supporting
individuals of the study management team in completing their
scientific degrees.
Quantitative Data Analysis
Feasibility of the intervention was assessed by exploring changes
in the diagnostic status of any anxiety disorder or major
depressive disorder and symptom improvement of anxiety and
depression. Pre-post data were compared with paired t tests and
expressed by Cohen d and the 95% confidence interval [48,49].
We also reported the mean percentage of symptom improvement
per assessment scale. As this is a pilot feasibility trial exploring
data and not testing hypotheses, we decided not to implement
any strategies to estimate missing data and instead used
completer data only. Due to the explorative nature of the trial,
we also did not control the global significance level for the
multiple testing problem. We also report baseline differences
as median comparisons between self-report assessment
completers and noncompleters investigated by the
Mann-Whitney U test.
Qualitative Data Analysis
The recorded interviews were transcribed verbatim according
to a predefined transcription guide. Content analysis and coding
rules followed recommendations by Mayring [50]. The software
program MAXQDA version 18.0.0 (VERBI GmbH) was used
to analyze the qualitative data. Adherence to standards for
reporting qualitative research was ensured by following the
consolidated criteria for reporting qualitative research (COREQ)
[51,52].
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Taking an inductive approach, codes were developed by two
researchers (KKW, LK) who used 50% of the raw data mindful
of the topical domains. Codes were discussed until agreement
was reached for a preliminary category system. Following this,
the other 50% of raw data were analyzed by identifying codes
and sorting them into the existing category system. If the codes
did not match the existing system, the system was adapted by
adjusting codes or creating new ones. The two researchers then
discussed the coding and finalized the categorical system.
After finalization of the categorical system, two researchers
(KKW, MNC) independently coded 10% of the data and
analyzed their ratings in MAXQDA to determine an interrater
agreement which is reported in the form of Cohen kappa
(threshold was set to 10%). Figure 2 depicts the process of the
qualitative data analysis.
Figure 2. Study flow qualitative data analysis.
Results
Baseline Characteristics
In total, 49 participants were included in the study, of which
the majority was female (38/49, 78%). Participants were aged
40 years on average; the youngest participant aged 22 years and
the oldest 68 years. Apart from two participants who resided in
Switzerland and Austria, all others (47/49, 96%) had their
residence in Germany. More than half of the participants (27/49,
55%) lived in cities with less than 100,000 inhabitants; 45%
(22/49) of participants stated they lived in a city with more than
100,000 inhabitants. At baseline, all participants (49/49, 100%)
included in the study had at least one anxiety disorder, while
18% (9/49) had at least two anxiety disorders and 6% (3/49)
had three anxiety disorders. On average, participants had
heightened symptoms of anxiety with a mean value of 21.29
(SD 7.79) on the HAM-A, 10.31 (SD 4.11) on the GAD-7, 38.35
(SD 10.96) on the BAI, 10.20 (SD 8.58) on the PAS, and 20.51
(SD 14.97) on the SPS. They also showed heightened symptom
severity of depression with an average value of 8.92 (SD 4.41)
on the QIDS-C, 21.71 (SD 6.58) on the CES-D, and 11.04 (SD
4.31) on the PHQ-9.
Of all participants, 43% (21/49) had no prior experience with
psychotherapy and 57% (28/49) had some type of experience
with psychotherapy. Of the 28 individuals with prior treatment
experience, 32% (9/28) rated their experience as very helpful,
61% (17/28) found it somewhat helpful, and 7% (2/28) did not
find their treatment to have been helpful. Considering prior
experience with health-related trainings, 73% (36/49) claimed
to have some and 27% (13/49) did not. See Table 2 for an
overview.
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Table 2. Baseline characteristics (n=49).
ValueCharacteristics
Sociodemographic characteristics
40.45 (12.9)Age in years, mean (SD)
38 (78)Gender, female, n (%)




Number of inhabitants, n (%)











1 (2)8 years of schooling
5 (10)10 years of schooling
19 (39)Abitur or 3 to 3.5 year traineeship
8 (16)Bachelor or equivalent
15 (31)Masters or equivalent
1 (2)Doctorate degree
Previous psychological treatment, n (%)
28 (57)Yes
21 (43)No




Previous experience with health-related trainings, n (%)
36 (73)Yes
13 (27)No
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aHAM-A: Hamilton Anxiety Rating Scale.
bGAD-7: Generalized Anxiety Disorder–7 item.
cBAI: Beck Anxiety Inventory.
dPAS: Panic and Agoraphobia Scale.
eSPS: Social Phobia Scale.
fQIDS-C: Quick Item Inventory of Depressive Symptomatology.
gCES-D: Center for Epidemiological Studies Depression Scale.
hPHQ-9: Patient Health Questionnaire–9 item.
Assessment Completion
In total, 43 (43/49, 88%) qualitative interviews were conducted.
The 6 individuals who did not complete the interview dropped
out of the study, 2 of which informed the study team they did
not want to continue and the other 4 could no longer be reached.
The interview duration ranged from 1 minute 51 seconds to 8
minutes 21 seconds. The interrater agreement of codes in 10%
of the interview data was 81% between raters (KKW, MNC).
As the quantitative analysis was based on assessment completer
data and we had an assessment dropout of 16% (8/49), we
additionally investigated baseline differences of symptom
severity and intervention adherence rates of quantitative
assessment completers and noncompleters (did not complete
the web-based assessment at postintervention). Depression and
anxiety symptom severity did not differ significantly between
those who dropped out and those who completed the
assessments. However, completers had significantly lower
anxiety levels on the BAI (median 33) compared with
noncompleters (median 44.50, U=80.5, z=–2.27, P=.02). For a
complete overview of baseline differences, see Multimedia
Appendix 1.
Impact
Considering changes in diagnostic status at postassessment, of
the individuals who completed the diagnostic interview, 46%
(18/39) still had at least one anxiety disorder while 54% (21/39)
no longer were diagnosed as having any anxiety disorder. There
was a significant improvement of anxiety symptoms assessed
by the HAM-A from 20.71 (SD 7.87, n=42) at baseline to 12.76
at postassessment (SD 9.18, n=42, T=7.0, df=41, P<.001,
d=1.19, 95% CI 0.73 to 1.66), which translates to a mean
symptom improvement of 38%. There was also a significant
improvement of symptoms of depression assessed by the
QIDS-C [38], from 8.4 (SD 4.13, n=42) to 6.38 at
postassessment (SD 4.83, n=42, T=2.51, df=41, P=.016, d=0.42,
95% CI 0.01 to 0.86), which is a mean symptom of improvement
of 24%.
All scales assessing anxiety symptom severity and depression
symptom severity showed a significant improvement from
baseline to postassessment. We also observed an improvement
on the PAS [42] from baseline (mean 9.66 [SD 8.59], n=41) to
postassessment (mean 8.12 [SD 7.06], n=41), which was not
significant (T=1.86, df=40, P=.07, d=0.28, 95% CI –0.16 to
0.71). For a full overview see Tables 3 and 4.
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Table 3. Completer baseline and postintervention data.



























bdf: degree of freedom.
cHAM-A: Hamilton Anxiety Rating Scale.
dGAD-7: Generalized Anxiety Disorder–7 item.
eBAI: Beck Anxiety Inventory.
fPAS: Panic and Agoraphobia Scale.
gSPS: Social Phobia Scale.
hQIDS-C: Quick Item Inventory of Depressive Symptomatology.
iCES-D: Center for Epidemiological Studies Depression Scale.
jPHQ-9: Patient Health Questionnaire–9 item.
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Table 4. Diagnostic status depression and anxiety.






















Two or more anxiety disorders
9/49 (18)T1
7/39 (18)T2
Three or more anxiety disorder
3/49 (6)T1
1/39 (3)T2
Subclinical depression b CES-D c ≥16
41/49 (84)T1
20/41 (49)T2
aMINI: Mini International Neuropsychiatric Interview.
bSubclinical depression subgroup (CES-D ≥16) assessed by Center for Epidemiological Studies Depression Scale.
cCES-D: Center for Epidemiological Studies Depression Scale.
Any type of positive training effect was mentioned in 84%
(36/43) of interviews while any type of negative training effect
was identified in 30% (13/43). Only 2 interviews with negative
effects had no mention of any positive effects; in one of these
interviews, training discontinuation was mentioned.
Positive training effects stated were improvement of disease
burden (n=26) including general improvement of disease burden
(n=12), feeling of increased performance (n=3), improvement
of depressive symptoms (n=2), less rumination (n=2),
improvement of psychosomatic pain (n=1), reduction of suicidal
and self-injurious thoughts (n=1), fewer panic attacks (n=1),
less tension (n=1), more calmness (n=1), reduction of alcohol
consumption (n=1), and improved sleep quality (n=1);
attentiveness to feelings and risk situations (n=24); confrontation
with one’s situation (n=20) including acceptance of oneself and
others (n=8), focus on important areas of life (n=4),
improvement of self-worth (n=2), knowing that one’s situation
can change (n=2), preoccupation with oneself (n=1), proud of
one’s achievements (n=1), and excited for future changes (n=1);
insights and suggestions (n=12); more awareness for positivity
and increased gratitude (n=6); and helpful entry to psychological
treatment (n=1). Satisfaction with the online treatment was
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categorized as online treatment helpful (n=5), fulfilled
expectations (n=6), excited about online treatment (n=6), and
online treatment not helpful (n=4).
Negative training effects entailed lack of change in disease
burden (n=11); symptom deterioration (n=9) including increased
hopelessness (n=5), increased rumination (n=2), social
withdrawal due to tension (n=1), general symptom deterioration
(n=1); and training discontinuation (n=1).
Intervention Use
In total, 98% (48/49) of participants completed the first session,
and 65% (32/49) completed all 7 sessions. The booster session
was completed by 55% (27/49). On average, participants took
on average 9.44 (SD 3.78) weeks (range 4-18 weeks) to
complete the intervention. See Table 5 for an overview.
Table 5. Completion rates.
Participants who did not complete session, n (%)Participants who completed session, n (%)Completion
1 (2)48 (98)Session 1
5 (10)44 (90)Session 2
7 (14)42 (86)Session 3
9 (18)40 (82)Session 4
11 (22)38 (78)Session 5
16 (33)33 (67)Session 6
17 (35)32 (65)Session 7
22 (45)27 (55)Booster session
In the noncompleter group, adherence intervention completion
ranged from 0 to 3 sessions, while in the completer group, the
average completion rate was mean 7.15 (SD 1.42) sessions.
Of the 38 participants who completed the fifth training session,
58% (22/38) chose to practice exposure to fear-inducing
situations, while the other 42% (16/38) chose to practice
problem-solving skills.
Regarding Tiny Tasks, only 10% (5/48) of individuals opted to
not receive them, while 58% (28/48) chose to receive the light
version with 3 daily reminders and motivational tasks and 31%
(15/48) opted for the intense version with 5 messages per day.
Motivation and Expectations
When asked in the online-based baseline assessment which type
of guidance participants would like to receive, 74% (36/49)
stated they would like guidance and feedback on completed
training session, no one said they did not want guidance, and
27% (13/49) claimed they had no preference concerning
guidance.
In the baseline assessment we asked the participants to select
reasons, from predefined categories, why they wanted to
participate in the online training. Almost all participants (47/49,
96%) selected the answer “I want to learn to cope with my
complaints autonomously.” Approximately 67% (33/49) claimed
that they found online training appealing and 31% (15/49) said
that waiting times for psychotherapy are too long. For a
complete overview see Multimedia Appendix 1.
There were 12 reasons associated with training motivation
identified in the qualitative interviews: advantages of online
treatment (n=38) including active self-help (n=29), time and
place independent flexible use (n=4), anonymity and to not have
to conduct face-to-face conversations (n=4), and something
beyond self-help (n=1); symptom burden (n=29) including
symptoms of anxiety and depression (n=18), not able to deal
with one’s situation autonomously (n=5), unhappy with current
life situation (n=2), sleep problems (n=2), loneliness (n=1), and
feeling of putting burden on family (n=1); openness toward
online treatment (n=12); desire for improvement (n=9); no
expectations toward the online treatment (n=7); stressful life
event (n=4); desire to better understand situation (n=3); negative
psychotherapy experience (n=3); no face-to-face psychotherapy
possible (n=3); heightened expectation of improvement by
participation (n=3); interest in psychology and mental health
(n=2); and positive experience with self-help (n=1). For a
complete overview see Multimedia Appendix 1.
Helpful and Hindering Factors
In total, 16 helpful factors and 10 hindering factors were
identified. Of all interviews, 98% (42/43) had some mention of
helpful factors and 74% (32/43) had some mention of hindering
factors.
Helpful factors encompassed psychoeducation (n=14); support
(n=20) including support by an eCoach (n=13), reminder emails
(n=4), app notifications (n=2), and diagnostic interview (n=1);
practice strategies in daily life (n=9); the structure of the
program (n=8); relatable stories of testimonials (n=7); practicing
thought protocol (n=7); planning activities (n=7); write down
problems (n=7); confrontation with personal needs and values
(n=7); elective modules (n=6); focus on personal situation (n=5);
individual tailoring (n=4); neutral perspective on situations
(n=3); problem solving (n=3); concrete instructions (n=2); and
strategy collection (n=1). When individuals mentioned change
but also stated that it could not directly be traced back to the
training, it was categorized as other reasons for the change in
disease burden (n=5).
Hindering factors comprised too little individualization of
intervention (n=29) including too standardized (n=12), online
treatment not sufficient (n=9), no feedback to specific inquiries
(n=5), and too little personal contact (n=3); being overwhelmed
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by the content and pace (n=15); usability issues (n=8) including
limited functionality of the app (n=6) and limited usability of
weekly activity plan (n=2); difficulties doing exercises (n=7);
motivational difficulties (n=6); difficulties to plan (n=3); not
open to training elements (n=1); needs beyond the scope of the
training (n=1); and stress (n=6).
Modification Requests
There were 10 types of modification requests made, which were
the desire for more intense support and more individualized
feedback (n=10); longer treatment duration or more time to
complete a module (n=9); exchange options with other
participants (n=3); have limits of online treatment stressed (n=3);
first aid plan (n=2); clearer structure of the activity plan (n=2);
more printable content (n=2); more support to enhance
motivation (n=2); more alternatives after having tried exercises




The aim of this pilot feasibility study was to investigate an
individually tailored transdiagnostic guided internet intervention
for anxiety disorders with and without comorbid subclinical
depression with an embedded qualitative and quantitative
process evaluation.
Overall, the intervention was found to be feasible and results
indicate potential efficacy concerning the improvement in
anxiety and depression symptom severity. Moderate to large
within effect sizes were found for anxiety and moderate effects
for depression severity on all assessment scales apart from the
PAS. Another finding in favor of the potential of the intervention
is that while all individuals had an anxiety disorder at baseline,
we found that the overall rate of anxiety disorders decreased by
more than half. Positive effects stated by participants were
general improvement of disease burden including improvement
of anxiety and depression symptom severity and feeling
equipped to deal with risk situations in the future. These findings
are in line with previous work indicating that internet
interventions are effective in treating anxiety disorders [1-3]
and different anxiety disorders and comorbid depressive
symptoms can be addressed transdiagnostically in one
intervention [27,53-55].
Adherence to the intervention was found to be satisfactory with
65% of participants completing the intervention as intended,
which lies just below some findings of adherence of
internet-based guided self-help for anxiety disorders with 75%
in a tailored group and 70.5% in a standardized treatment group
[25]. The most prevalent reasons for participation found were
advantages of the online treatment, symptom burden, and a
general openness toward the online treatment. Participants found
the most helpful factors to be the support provided, the
psychoeducation, and being taught and encouraged to practice
strategies in their daily routines.
Certain factors were perceived as hindering, such as the
treatment not being individualized enough, at time they felt
overwhelmed by the content and pace, and there were some
usability issues. Some individuals struggled with motivation,
regularly practicing, and integrating exercises into their daily
lives, and others perceived stress outside of the intervention to
be negative toward change. Many individuals also expressed
the wish to have more contact with their eCoach going beyond
the written messages and would have liked to have a personal
conversation with their eCoach.
We also identified some negative effects. Although the
quantitative data clearly showed an average improvement of
anxiety and depression, the qualitative data revealed some
negative effects such as an experienced lack of change in disease
burden and symptom deterioration. Some individuals had
heightened expectations of improvement prior to the treatment,
which might be linked to greater disappointment and
hopelessness if the treatment was perceived as ineffective. The
negative effects were similar to what has been found in previous
work, such as the occurrence of symptom deterioration or the
emergence of novel symptoms [56]. When considering these
negative effects, it is important to keep in mind that the
individuals often mentioned negative and positive effects in one
interview. This finding indicates that although many individuals
improved in many different areas of life, it is possible that they
did not improve in all the areas they would have liked to, it was
not as effective as they expected, or they were not able or willing
to put in the work to achieve the change they would have liked
to experience. Although the number of negative effects
mentioned was much less pronounced than positive treatment
impact, this finding indicates the importance of exploring the
use of methods beyond quantitative data such as qualitative
data, as it can provide a more nuanced insight into user
experience.
Strengths and Limitations
This study has the following strengths: the combination of
qualitative and quantitative methods; having a total of 43
independent voices included in the qualitative data analysis;
conducting clinical interviews to assess diagnostic status; the
high standard of conducting the qualitative analysis; the
following of current recommendations in the field; and the high
interrater reliability between coders.
This study also has some limitations. As this was an uncontrolled
pilot feasibility study with an intervention group and no control
group, there was an explorative analysis of only within pre-post
data and there was no actual hypothesis testing; also, we did
not apply any techniques to estimate missing data. The already
small sample size was further decimated by study dropouts.
Although we completed some statistical analyses of the
quantitative data, the results should be interpreted with caution
as the findings are based on a very small, self-selected,
completer data sample. This should be kept in mind when
regarding the quantitative findings. After investigating baseline
symptom severity differences between assessment completers
and noncompleters, we saw that noncompleters had higher
symptom severity of anxiety on the BAI on average; therefore,
it is possible that the effects based on completers only are an
overestimation. Furthermore, individuals with a major
depressive disorder at baseline were excluded from the study
during the screening process to increase internal study validity.
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As participants self-selected to participate in the study, which
is a typical occurrence in studies conducted in general population
samples, this was an investigation of a highly selective
population of individuals with an anxiety disorder, and findings
from the qualitative data might not be generalizable to other
populations. Also, the qualitative interview was completed after
the intervention phase; therefore, questions on motivation and
expectations were assessed in a retrospective manner and might
be biased due to memory errors and time lapse. Last, it is
possible that attrition rates are higher than they would be in a
natural setting as the specificities of the study design such as
diagnostic interviews might positively influence adherence.
Learnings and Future Research
Our learnings for future studies when targeting individuals with
anxiety disorders are that it is important to emphasize the
self-help aspect of internet interventions, replace clinical and
disorder-specific terms, highlight the flexible use options, and
provide detailed information on what individuals can expect.
Although the intervention was heavily individualized and
contained many elements of individual tailoring, participants
still preferred to have the individualization options increased.
First, future research should focus on the dose-response rate
posing the question how flexible a treatment can be while still
producing a positive outcome. Second, future research should
investigate whether further individualization also increases
initial acceptance and willingness to participate, which might
increase the effects on a population level. Individual tailored
interventions for anxiety and depression should also be
systematically compared with standardized disorder specific
treatment in one study.
Although not all individuals experienced negative effects, it
still seems especially relevant to address negative effects due
to their possible impact. If an individual who suffers from a
mental disorder and has taken the step to seek treatment has a
negative treatment experience, it could cause training
discontinuation, detraction from seeking further psychological
treatment, and chronification of symptomology, which is why
it is important to intervene in a timely manner. One first step
to address this would be to manage realistic expectations before
and throughout the intervention, clarify possible limits of an
online treatment, and engage or refer individuals after an
intervention. To tackle issues of motivation and difficulties
integrating exercises into daily life, it could be helpful to involve
smartphones more often into the treatment protocol as they
could function as an extension of the treatment into individuals’
private lives and are practical to deliver reminders. Future
interventions should create a well-rounded support and guidance
system that includes guidance adaptable in intensity combined
with adherence and symptom monitoring.
There might also be other indicators of differential treatment
outcome such as symptom severity, previous experience with
mental health treatment, fear of stigma, and expectation of
improvement, factors that could explain who benefits from
internet interventions and who does not. For this reason, it is
important to not only understand mediators of treatment but
also investigate moderators of treatment and the combination
of both. We also believe qualitative research should be used to
understand why some individuals do not respond to treatment.
Concerning future qualitative research, it would be interesting
to use machine learning techniques to analyze data. This could
be done by analyzing content and words used by patients (eg,
how someone speaks about themselves and their progress) as
well as features of speech such as coherence, intonation,
amplitude, pitch, and timbre. In addition to using these features
to investigate user experience and impact, they might also be
useful as an additional outcome assessment.
Conclusion
The investigated individually tailored transdiagnostic guided
internet intervention seems to be feasible and indicated potential
to reduce anxiety and depression severity. The results suggest
that when targeting individuals for this type of treatment, it can
be helpful to emphasize the active self-help components in
addition to the advantages of online treatments. The content
should contain psychoeducation, emphasize practicing strategies
in daily life, and be complemented by a support system that
entails some type of guidance as well as adherence and symptom
monitoring. Once thresholds for low adherence or heightened
symptoms are crossed, mechanisms should be set in place to
either adapt the intervention or guide individuals to further
treatment. Further individualization of interventions should be
explored to best adapt to patients’ characteristics, needs, and
preferences.
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